Morgan Stanley Schedule 13G passive stakes

NYSE
Morgan Stanley has filed an amendment to its Schedule 13G, reporting that it no longer beneficially owns more than five percent of Apellis Pharmaceuticals common stock.
NYSE
Morgan Stanley and its affiliates have filed a Schedule 13G reporting a 10.1% beneficial ownership stake in Blackbaud Inc.
NYSE
Morgan Stanley has filed a Schedule 13G reporting a 10% beneficial ownership stake in Aurora Innovation, Inc. Class A common stock.
NYSE
Morgan Stanley and affiliated entities have filed a Schedule 13G reporting a 6.2% beneficial ownership stake in Presidio Production Company.
NYSE
Morgan Stanley has filed a Schedule 13G reporting a 7.3% beneficial ownership stake in TGE Value Creative Solutions Corp.
NYSE
Morgan Stanley has filed a Schedule 13G disclosing a 7.1% beneficial ownership stake in XPLR Infrastructure, LP.
NYSE
Morgan Stanley and its subsidiary, Morgan Stanley Smith Barney LLC, have filed a Schedule 13G, reporting beneficial ownership of 17.8% of Western Asset Premier Bond Fund's common shares.
NYSE
Morgan Stanley and its subsidiary, Morgan Stanley Capital Services LLC, have filed an amended Schedule 13G, reporting beneficial ownership of 7.2% of Radware Ltd.'s ordinary shares as of March 31, 2026.
NYSE
Morgan Stanley and its subsidiary, Morgan Stanley Capital Services LLC, have filed a Schedule 13G detailing their beneficial ownership of JBG SMITH Properties common shares.
NYSE
Morgan Stanley and its subsidiary, Morgan Stanley Smith Barney LLC, have disclosed beneficial ownership of 3,290,012 shares, representing 8.9% of the common stock in First Trust High Yield Opportunities 2027 Term Fund.
NYSE
Morgan Stanley and its subsidiary, Morgan Stanley Investment Management Inc., have filed an amendment to their Schedule 13G, indicating they no longer beneficially own more than five percent of Samsara Inc.'s Class A common stock.
NYSE
Morgan Stanley and Atlanta Capital Management Company, LLC report beneficial ownership of WEX Inc. common stock as of March 31, 2026.
NYSE
Morgan Stanley and its subsidiary, Morgan Stanley Capital Services LLC, have filed an amended Schedule 13G, reporting beneficial ownership of Sphere Entertainment Co. Class A Common Stock.
NYSE
Morgan Stanley and its subsidiary, Morgan Stanley Investment Management Inc., have filed a Schedule 13G, reporting beneficial ownership of Roivant Sciences Ltd. common shares.
NYSE
Morgan Stanley and its subsidiary, Morgan Stanley Smith Barney LLC, have jointly filed a Schedule 13G, reporting beneficial ownership of 7.8% of Nuveen S&P 500 Dynamic Overwrite Fund's common shares as of March 31, 2026.
NYSE
Morgan Stanley has filed a Schedule 13G, reporting a beneficial ownership of 2.6% in Perspective Therapeutics, Inc. as of March 31, 2026, indicating a reduction in its holdings.
NYSE
Morgan Stanley and its subsidiary, Morgan Stanley Capital Services LLC, have filed a Schedule 13G indicating their beneficial ownership of Jasper Therapeutics, Inc. common stock.
NYSE
Morgan Stanley and its subsidiary, Morgan Stanley Smith Barney LLC, have filed a Schedule 13G, reporting beneficial ownership of 11.4% of Guggenheim Taxable Municipal Bond & Investment Grade Debt Trust.
NYSE
Morgan Stanley has filed an amendment to its Schedule 13G, reporting a decrease in its beneficial ownership of Trimble Inc. common stock to below the 5% threshold.
NYSE
Morgan Stanley has filed an amended Schedule 13G, indicating its beneficial ownership of Seven Hills Realty Trust's common shares has fallen below the 5% threshold.
NYSE
Morgan Stanley and its subsidiary, Morgan Stanley Smith Barney LLC, have filed a Schedule 13G, reporting beneficial ownership of 7.5% of RiverNorth/DoubleLine Strategic Opportunity Fund, Inc.'s Series A Cumulative Perpetual Preferred Stock.
NYSE
Morgan Stanley and its subsidiary, Morgan Stanley Capital Services LLC, have filed a Schedule 13G, reporting beneficial ownership of 5.9% and 5.8% of Turtle Beach Corp. common stock, respectively, as of March 31, 2026.
NYSE
Morgan Stanley and its subsidiary, Morgan Stanley Investment Management Inc., have filed a Schedule 13G, indicating their beneficial ownership of LandBridge Co LLC Class A Shares has fallen below the 5% threshold.
NYSE
Morgan Stanley and its subsidiary, Morgan Stanley Smith Barney LLC, have filed a Schedule 13G, reporting beneficial ownership of 5.6% of KKR Income Opportunities Fund's common shares as of March 31, 2026.
NYSE
Morgan Stanley and its subsidiary, Morgan Stanley Smith Barney LLC, have filed a Schedule 13G, reporting beneficial ownership of 6.5% of Western Asset Emerging Markets Debt Fund Inc. common stock.
NYSE
Morgan Stanley and its subsidiary, Morgan Stanley Capital Services LLC, have filed an amendment to their Schedule 13G, reporting changes in their beneficial ownership of Terns Pharmaceuticals, Inc. common stock.
NYSE
Morgan Stanley and its subsidiary, Morgan Stanley Capital Services LLC, have filed a Schedule 13G detailing their beneficial ownership of Six Flags Entertainment Corporation/NEW common stock.
NYSE
Morgan Stanley and its subsidiary, Morgan Stanley Smith Barney LLC, have filed a Schedule 13G, reporting beneficial ownership of 15.5% of RiverNorth/DoubleLine Strategic Opportunity Fund, Inc.'s 4.75% Series B Cumulative Preferred Shares.
NYSE
Morgan Stanley has disclosed beneficial ownership of 5.3% of Vertex, Inc.'s Class A Common Stock as of March 31, 2026.
NYSE
Morgan Stanley and its subsidiary, Morgan Stanley Smith Barney LLC, have filed a Schedule 13G, disclosing beneficial ownership of 5.2% of Nuveen Real Estate Income Fund's common shares as of March 31, 2026.